FIM
EW icon

Foresters Investment Management’s Edwards Lifesciences EW Stock Holding History

Foresters Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,078
Closed -$341K – 450
2017
Q4 		$341K Sell
9,078
-1,536
-14% -$56.4K 0.01% 430
2017
Q3 		$387K Sell
10,614
-525
-5% -$20K 0.01% 403
2017
Q2 		$439K Buy
+11,139
New +$407K 0.01% 382

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Foresters Investment Management's EW Position: Q1 2018 in Review

Foresters Investment Management sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 9,078 shares — an estimated $341K sold.

Foresters Investment Management first reported a position in EW in Q2 2017 and held it in 3 quarters. The position peaked at $439K in Q2 2017. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

  • Foresters Investment Management reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
  • Foresters Investment Management sold 9,078 Edwards Lifesciences shares in Q1 2018, an estimated $341K.
  • Foresters Investment Management first reported a position in Edwards Lifesciences in Q2 2017 and held it in 3 quarters.
  • Foresters Investment Management's Edwards Lifesciences position peaked at $439K in Q2 2017.
  • 815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on Foresters Investment Management's 13F filing for Q1 2018, filed 11 May 2018.